Personalized diet may boost Well-Being in advanced cancer patients

NCT ID NCT07406789

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a personalized diet can improve quality of life in 100 women with advanced gynecologic or breast cancer who are receiving antibody-drug conjugate therapy. Participants will either follow a diet tailored to their needs or receive general Mediterranean diet advice. The goal is to see if personalized nutrition helps them feel better during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
personalized dietary intervention
What this could lead to
If it works, this could show that tailoring diet to individual needs helps women with advanced cancer feel better during treatment.
What could go wrong
This is a small, early-phase study focused on quality of life, not survival. The diet may not provide noticeable benefits, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Hospital Universitario 12 Octubre

    Madrid, Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.